Mr Carter joined Actinogen in September 2020 and has more than 30 years of expertise in professional accounting, investment banking, corporate finance and commercial / strategic planning roles. He has served as a member of the board on a USA based company. He was the chief financial officer of the company until it’s move to the USA at the end of 2009. Since the beginning of 2000 he has served as chief financial officer and company secretary of various publicly listed healthcare and biotech companies. Prior to his move into the healthcare sector he also held senior positions with Coca Cola Amatil, Santos, Canadian Imperial Bank of Commerce and Touche Ross.
Mr Carter holds a Bachelor of Financial Administration (UNE) and a Master of Applied Finance (Macquarie University) and is a qualified Chartered Accountant.
Mr Carter is also the Chief Financial Officer of Amplia Therapeutics Limited (ASX:ATX) since 2013.